Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients

ConditionDiabetic Neuropathy

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexMale

Age40-60

SponsorAswan University

About this trial

study the relationship of vitamin d with nerve growth factor level and nerve conduction studies in adult male type 2 diabetic neuropathy patients

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult male patients 40 -65 years' old who have type 2 diabetes mellitus on oral hypoglycemic , non-diabetic healthy subjects of matched age and type 2male diabetic neuropathy patients of matched age .

Disqualifiers

Cardiac patients.

Patients who have transient ischemic attack or stroke.

Patients with inflammatory rheumatic diseases.

Patients with malignant diseases.

Trial population

Group І: Control group included non-diabetic healthy males. Group П: Type 2 male diabetic patients not suffering from diabetic neuropathy in Aswan University Hospital of matched age. Group III: Type 2 male diabetic patients suffering from diabetic neuropathy in Aswan University Hospital of matched age.

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

nerve conduction studies
Other intervention
Assessment of neuropathy by nerve conduction studies of sural and tibial nerves in both lower extremities.
Nerve Growth Factor
Other intervention
nerve growth factor level using its corresponding ELISA kit
25(OH) vitamin D
Other intervention
25(OH) vitamin D serum level using its corresponding ELISA kit

Treatment groups

57 Participants

are divided into 3 treatment groups

Group A: control group1 intervention

Group B: type 2 diabetic male not suffering from diabetic neuropathy aged(40-60) years old1 intervention

Group C: type2 diabetic males suffering from diabetic neuropathy aged(40_60)years old1 intervention

Trial outcomes

Primary outcomes

study the relation of vitamin d and nerve growth factor with nerve conduction studies in type 2 diabetic neuropathy male patients

1. Difference in vitamin D level between diabetic neuropathy patients, diabetic patients without neuropathy and healthy subjects. 2. Difference in serum nerve growth factor level between diabetic neuropathy patients, diabetic patients without neuropathy and healthy subjects.

Time frame

one year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aswan University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: